{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:19:45Z","timestamp":1774621185195,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12801-0","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:47:26Z","timestamp":1771670846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Active surveillance of cytomegalovirus and pulmonary aspergillosis in critically ill patients with COVID-19: risk assessment of high-dose steroids"],"prefix":"10.1186","volume":"26","author":[{"given":"Jung Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Yeop","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyeon","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Keun","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyoung","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"12801_CR1","doi-asserted-by":"crossref","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020.","DOI":"10.1056\/NEJMoa2001017"},{"issue":"1","key":"12801_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","volume":"191","author":"JN Gustine","year":"2021","unstructured":"Gustine JN, Jones D. Immunopathology of hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4\u201317.","journal-title":"Am J Pathol"},{"key":"12801_CR3","unstructured":"Chappell L, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A. Dexamethasone in hospitalized patients with COVID\u201419-preliminary report. N Engl J Med. 2020."},{"issue":"5","key":"12801_CR4","doi-asserted-by":"publisher","first-page":"e0252057","DOI":"10.1371\/journal.pone.0252057","volume":"16","author":"MA Pinz\u00f3n","year":"2021","unstructured":"Pinz\u00f3n MA, Ortiz S, Holgu\u00edn H, Betancur JF, Cardona Arango D, Laniado H, Arias Arias C, Mu\u00f1oz B, Quiceno J, Jaramillo D. Dexamethasone vs Methylprednisolone high dose for Covid-19 pneumonia. PLoS ONE. 2021;16(5):e0252057.","journal-title":"PLoS ONE"},{"issue":"10","key":"12801_CR5","doi-asserted-by":"publisher","first-page":"e0275217","DOI":"10.1371\/journal.pone.0275217","volume":"17","author":"H Wu","year":"2022","unstructured":"Wu H, Daouk S, Kebbe J, Chaudry F, Harper J, Brown B. Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial. PLoS ONE. 2022;17(10):e0275217.","journal-title":"PLoS ONE"},{"key":"12801_CR6","doi-asserted-by":"crossref","unstructured":"Bhatt K, Agolli A, Patel MH, Garimella R, Devi M, Garcia E, Amin H, Domingue C, Del Castillo RG, Sanchez-Gonzalez M. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova). 2021;9(1).","DOI":"10.15190\/d.2021.5"},{"issue":"3","key":"12801_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10238-021-00751-7","volume":"22","author":"A Abdoli","year":"2022","unstructured":"Abdoli A, Falahi S, Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin Experimental Med. 2022;22(3):327\u201346.","journal-title":"Clin Experimental Med"},{"issue":"5","key":"12801_CR8","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cmi.2020.12.005","volume":"27","author":"S Delli\u00e8re","year":"2021","unstructured":"Delli\u00e8re S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic P-A, Salmona M, D\u00e9pret F, Ghelfenstein-Ferreira T, Plaud B. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2021;27(5):790. e791-790. e795.","journal-title":"Clin Microbiol Infect"},{"key":"12801_CR9","doi-asserted-by":"crossref","unstructured":"Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection. 2022:1\u201314.","DOI":"10.1007\/s15010-021-01701-x"},{"issue":"6","key":"12801_CR10","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SC, Colombo AL, Hoenigl M, Klimko N, Lass-Fl\u00f6rl C, Oladele RO, Vinh DC. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149\u201362.","journal-title":"Lancet Infect Dis"},{"key":"12801_CR11","unstructured":"World Health Organization. Clinical management of COVID-19: living guideline-15 September 2022. Geneva: World Health Organization; 2022."},{"key":"12801_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03221-w","volume":"24","author":"P Ichai","year":"2020","unstructured":"Ichai P, Saliba F, Baune P, Daoud A, Coilly A, Samuel D. Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients. Crit Care. 2020;24:1\u20133.","journal-title":"Crit Care"},{"issue":"3","key":"12801_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3390\/jof8030316","volume":"8","author":"T de la Pel\u00e1ez-Garc\u00eda","year":"2022","unstructured":"de la Pel\u00e1ez-Garc\u00eda T, Gonz\u00e1lez-Jim\u00e9nez I, Fern\u00e1ndez-Arroyo A, Rold\u00e1n A, Carretero-Ares JL, Garc\u00eda-Clemente M, Telenti-Asensio M, Garc\u00eda-Prieto E, Mart\u00ednez-Suarez M. V\u00e1zquez-Vald\u00e9s F: COVID-19 associated pulmonary aspergillosis (CAPA): hospital or home environment as a source of Life-Threatening Aspergillus fumigatus infection? J Fungi. 2022;8(3):316.","journal-title":"J Fungi"},{"issue":"4","key":"12801_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.300.4.413","volume":"300","author":"AP Limaye","year":"2008","unstructured":"Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang M-L, Santo Hayes TK, Corey L. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300(4):413\u201322.","journal-title":"JAMA"},{"issue":"3","key":"12801_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14776\/piv.2018.25.e8","volume":"25","author":"SR Choi","year":"2018","unstructured":"Choi SR, Kim K-R, Kim DS, Kang J-M, Kim SJ, Kim JM, Oh S-y, Kang C-I, Chung DR, Peck KR. Changes in cytomegalovirus Seroprevalence in Korea for 21 years: a single center study. Pediatr Infect Vaccine. 2018;25(3):123\u201331.","journal-title":"Pediatr Infect Vaccine"},{"issue":"11","key":"12801_CR16","doi-asserted-by":"publisher","first-page":"e3634","DOI":"10.1371\/journal.pone.0003634","volume":"3","author":"T Widmann","year":"2008","unstructured":"Widmann T, Sester U, G\u00e4rtner BC, Schubert J, Pfreundschuh M, K\u00f6hler H, Sester M. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS ONE. 2008;3(11):e3634.","journal-title":"PLoS ONE"},{"issue":"3","key":"12801_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","volume":"51","author":"A Simonnet","year":"2021","unstructured":"Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, Robriquet L, Hober D, Jourdain M. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis now. 2021;51(3):296\u20139.","journal-title":"Infect Dis now"},{"issue":"6","key":"12801_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00134-022-06716-y","volume":"48","author":"I Gatto","year":"2022","unstructured":"Gatto I, Biagioni E, Coloretti I, Farinelli C, Avoni C, Caciagli V, Busani S, Sarti M, Pecorari M, Gennari W, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med. 2022;48(6):706\u201313.","journal-title":"Intensive Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12801-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:18:48Z","timestamp":1774617528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12801-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12801"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12801-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Informed consent to participate was waived by the Institutional Review Board of Inha University Hospital (IRB No. 2022-10-021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"658"}}